Parallel Advisors »

Taysha Gene Therapies shares owned by Parallel Advisors

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $562 280 2.01
2024-06-30 $627 280 2.24
2021-12-31 $999 45 22.22

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Ishares Core Msci Eafe Etf Etf (IEFA)
Amazon.com Stock (AMZN)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Vanguard Total Stk Mkt Etf (VTI)
Costco Wholesale Corp Stock (COST)

View all positions for Parallel Advisors

Top funds holding Taysha Gene Therapies

BlackRock
BlackRock
RA Capital Management
VR Adviser
Morgan Stanley
Vanguard Group
Siren
Octagon Capital Advisors
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
Jpmorgan Chase & Co
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding Taysha Gene Therapies